Clinical trial
Osteoprotegerin (OPG) in Induced Sputum as a Novel Biomarker for COPD
NCT00655954 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Osteoprotegerin (OPG) in Induced Sputum as a Novel Biomarker for COPD
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- March 31, 2010
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.